HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 643 participants.

Also called NCT04571619

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 643 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04571619
Other papers using this trial's data
  • Adapting a pain coping skills training intervention for people with chronic pain receiving maintenance hemodialysis for end stage Kidney disease Journal of behavioral medicine, 2025-04 DOI, PubMed 39627496, PMC12512601 In the PMC Open Access subset under a licence that is not Creative Commons.
  • Pain Coping Skills Training for Patients Receiving Hemodialysis: The HOPE Consortium Randomized Clinical Trial JAMA internal medicine, 2025-02-01 DOI, PubMed 39786400, PMC11791705 PubMed links an erratum for this paper. Erratum: PMID 40063034 In the PMC Open Access subset under CC BY.
  • Social determinants of health as predictors of latent symptom clusters in patients undergoing maintenance hemodialysis: A secondary analysis of the HOPE consortium randomized trial The journal of pain, 2026-11 DOI, PubMed 42526778, PMC13621374 In the PMC Open Access subset under a licence that is not Creative Commons.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04571619. Randomized; no masking; primary purpose treatment. Start 2021-01-03 (actual); primary completion 2023-12-21 (actual). Results posted on 2025-01-13.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis
Acronym
HOPE
Condition
End Stage Renal Disease
Condition
Chronic Pain
Condition
Opioid Dependence
Intervention (Behavioral)
Pain Coping Skills Training (PCST)
Intervention (Drug)
Buprenorphine
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (class: US National Institutes of Health)
Collaborator
Hennepin Health Care (class: not stated)
Collaborator
New York University (class: other)
Collaborator
Massachusetts General Hospital (class: other)
Collaborator
University of Illinois Chicago (class: other)
Collaborator
University of Pittsburgh (class: other)
Collaborator
University of Washington (class: other)
Collaborator
University of New Mexico (class: other)
Collaborator
Rogosin Institute (class: not stated)
Collaborator
Vanderbilt University Medical Center (class: other)
Collaborator
West Virginia University (class: other)
Collaborator
Yale University (class: other)
Collaborator
Durham VA Health Care System (class: US federal agency)
Collaborator
VA Portland Healthcare System (class: not stated)
Collaborator
West Haven VA Medical Center (class: not stated)
Collaborator
University of Pennsylvania (class: other)
Collaborator
Dallas VA Medical Center (class: US federal agency)
Collaborator
VA New York Harbor Healthcare System (class: US federal agency)

Record details

Record id
cardio:ct-nct04571619
Content hash
303ac41936b84da170dbcfc49e127925fc39180881d00b17051c9576ef6a9f8c